Kendall Marcus

Company: FDA

Job title: Director Dermatology & Dentistry

Seminars:

FDA Perspective on JAK Inhibitor Development & Dermatologic Disorders 2:45 pm

Considering what clinical endpoints the FDA will accept across multiple disciplines within JAK inhibitor drug development to accelerate delivery to market Q&A Time: An extended 15 minute session post presentation to alleviate all JAK inhibitor pipeline queries and save labor downstreamRead more

day: Day Two